As if quitting smoking wasn’t hard enough: The FDA is slapping mental health warnings on varenicline and buprorpion, two drugs commonly prescribed to help smokers ditch their “cancer sticks,” as both medications may cause serious neuropsychiatric problems and could even provoke suicidal behavior among users.

ABC News:

Reports of behavioral changes, depressed mood, agitation, hostility and suicidal thoughts and behavior associated with use of the drugs have been submitted to the FDA’s adverse event reporting system.

Throughout the marketing history of the drugs, there have been 98 suicides and 188 attempted suicides in varenicline users and 14 suicides and 17 attempted suicides in buproprion users, the agency reported.

Read more

Rock Solid Journalism

In 2026, amid chaos and the nonstop flurry of headlines, Truthdig remains independent, fact-based and focused on exposing what power tries to hide.

Support Independent Journalism.

SUPPORT TRUTHDIG